Pomalidomide - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pomalidomide

Brand Name:

Pomalyst

Strength:

4 mg

HCPCS:

NA

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Immunomodulator

Minor Drug Class:

Thalidomide Analog

Oral (Y/N):

Yes

FDA Approval Year:

2013

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use